Colgate-Palmolive (NYSE: CL) had its price target raised by analysts at UBS Group AG from $105.00 to $109.00. They now have a "buy" rating on the stock.
Colgate-Palmolive (NYSE: CL) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Revlon Appoints Dana Medema as President, North America [Yahoo! Finance]
Colgate-Palmolive (NYSE: CL) had its price target lowered by analysts at Barclays PLC from $89.00 to $86.00. They now have an "equal weight" rating on the stock.
Colgate-Palmolive (NYSE: CL) had its price target lowered by analysts at JPMorgan Chase & Co. from $99.00 to $95.00. They now have an "overweight" rating on the stock.